Do Breast Implants Increase Cancer Risk?

Publication
Article
Oncology Nursing NewsFebruary 2011
Volume 5
Issue 1

The FDA is examining a potential link between breast implants and anaplastic large cell lymphoma (ALCL), a rare and aggressive form of non-Hodgkin lymphoma.

The FDA is examining a potential link between breast implants and anaplastic large cell lymphoma (ALCL), a rare and aggressive form of non-Hodgkin lymphoma. Federal health officials believe the implants might increase a woman’s risk of developing ALCL in the scar tissue next to the implant. The FDA’s findings are based on a review of scientific literature dating back to 1997, which includes 60 cases of ALCL in women with breast implants. Thus far, the FDA has been unable to identify a type of implant or reason for implant that may increase a woman’s risk. To facilitate its investigation, the FDA is creating a registry with the help of the American Society of Plastic Surgeons and other expert groups.

Related Videos
Marc J. Braunstein, MD, PhD
Rita Nanda, MD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Siddartha Yadav, MD, FACP
Jorge J. Castillo, MD,
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Alessandra Ferrajoli, MD